Skip Navigation

Cardiovascular Research 2004 64(1):52-60; doi:10.1016/j.cardiores.2004.06.009
© 2004 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Lowri Thomas, N.
Right arrow Articles by Anthony Lai, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lowri Thomas, N.
Right arrow Articles by Anthony Lai, F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2004, European Society of Cardiology

Functional heterogeneity of ryanodine receptor mutations associated with sudden cardiac death

N. Lowri Thomas, Christopher H. George* and F. Anthony Lai

Department of Cardiology, Wales Heart Research Institute, University of Wales College of Medicine, Heath Park, Cardiff, Wales CF14 4XN, UK

* Corresponding author. Tel.: +44-29-20744431; fax: +44-29-20743500. E-mail address: georgech{at}cf.ac.uk

Objectives: Point mutations in the cardiac ryanodine receptor (RyR2) mediate abnormal intracellular Ca2+ release and are associated with stress-induced ventricular tachycardia (VT), leading to sudden cardiac death (SCD). Although the precise molecular basis of RyR2 dysfunction in SCD remains controversial, there is consensus that the mutations characterised to date all exhibit gain-of-function Ca2+ release properties following cell stimulation. We investigated the functional impact of a distinct set of SCD-linked RyR2 mutations (L433P, N2386I, R176Q/T2504M) on intracellular Ca2+ handling. Methods: We expressed full-length recombinant human wild-type (WT) and SCD-linked RyR2 mutations in human embryonic kidney (HEK) cells, and profiled the spatial and amplitude characteristics of caffeine-evoked Ca2+ release through homo-tetrameric channels in living cells using rapid confocal laser scanning microscopy. Results: Analysis of the precise mode of Ca2+ release in HEK cells expressing RyR2 mutants demonstrated profound differences when compared with WT channels. The SCD-linked RyR2 mutations characterised in this study exhibited heterogeneous Ca2+ release profiles, including the novel observation that one of the mutants, (L433P), exhibited a marked reduction in sensitivity to channel activation. However, all SCD-linked RyR2 mutations characterised in this study resulted in an increased duration of elevated cytoplasmic Ca2+ levels following channel activation. Conclusions: Our live cell-based data demonstrates functional heterogeneity of Ca2+ release through SCD-linked RyR2 mutants, suggesting that the mechanistic basis of RyR2 dysfunction in SCD may be more complex than previously anticipated. These findings may have profound consequences for the therapeutic modulation of RyR2 in stress-induced VT and SCD.

KEYWORDS Arrhythmia (mechanism); Ca2+ channel; Calcium (cellular); Sudden death


Time for primary review 9 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
D. Jiang, W. Chen, R. Wang, L. Zhang, and S. R. W. Chen
Loss of luminal Ca2+ activation in the cardiac ryanodine receptor is associated with ventricular fibrillation and sudden death
PNAS, November 13, 2007; 104(46): 18309 - 18314.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. J. Kannankeril, B. M. Mitchell, S. A. Goonasekera, M. G. Chelu, W. Zhang, S. Sood, D. L. Kearney, C. I. Danila, M. De Biasi, X. H. T. Wehrens, et al.
Mice with the R176Q cardiac ryanodine receptor mutation exhibit catecholamine-induced ventricular tachycardia and cardiomyopathy
PNAS, August 8, 2006; 103(32): 12179 - 12184.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
I. Jona and P. P. Nanasi
Cardiomyopathies and sudden cardiac death caused by RyR2 mutations: Are the channels the beginning and the end?
Cardiovasc Res, August 1, 2006; 71(3): 416 - 418.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
Z. Yang, N. Ikemoto, G. D. Lamb, and D. S. Steele
The RyR2 central domain peptide DPc10 lowers the threshold for spontaneous Ca2+ release in permeabilized cardiomyocytes
Cardiovasc Res, June 1, 2006; 70(3): 475 - 485.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. H. George, H. Jundi, N. Walters, N. L. Thomas, R. R. West, and F. A. Lai
Arrhythmogenic Mutation-Linked Defects in Ryanodine Receptor Autoregulation Reveal a Novel Mechanism of Ca2+ Release Channel Dysfunction
Circ. Res., January 6, 2006; 98(1): 88 - 97.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. G. Priori and C. Napolitano
Intracellular Calcium Handling Dysfunction and Arrhythmogenesis: A New Challenge for the Electrophysiologist
Circ. Res., November 25, 2005; 97(11): 1077 - 1079.
[Full Text] [PDF]


Home page
Circ. Res.Home page
D. Jiang, R. Wang, B. Xiao, H. Kong, D. J. Hunt, P. Choi, L. Zhang, and S. R. W. Chen
Enhanced Store Overload-Induced Ca2+ Release and Channel Sensitivity to Luminal Ca2+ Activation Are Common Defects of RyR2 Mutations Linked to Ventricular Tachycardia and Sudden Death
Circ. Res., November 25, 2005; 97(11): 1173 - 1181.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. Kontula, P. J. Laitinen, A. Lehtonen, L. Toivonen, M. Viitasalo, and H. Swan
Catecholaminergic polymorphic ventricular tachycardia: Recent mechanistic insights
Cardiovasc Res, August 15, 2005; 67(3): 379 - 387.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Zissimopoulos and F. A. Lai
Interaction of FKBP12.6 with the Cardiac Ryanodine Receptor C-terminal Domain
J. Biol. Chem., February 18, 2005; 280(7): 5475 - 5485.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. M. Gomez and S. Richard
Mutant cardiac ryanodine receptors and ventricular arrhythmias: is 'gain-of-function' obligatory?
Cardiovasc Res, October 1, 2004; 64(1): 3 - 5.
[Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.